Publikationen von M. B. Müller

Schmidt, M. V.; Oitzl, M.; Steenbergen, P.; Lachize, S.; Wurst, W.; Müller, M. B.; de Kloet, E. R.; Meijer, O. C.: Ontogeny of steroid receptor coactivators in thehippocampus and their role in regulating postnatal HPA axis function. Brain Research 1174, S. 1 - 6 (2007)

Ganea, K.; Liebl, C.; Sterlemann, V.; Müller, M. B.; Schmidt, M. V.: Pharmacological validation of a novel home cage activity counter in mice. Pharmacopsychiatry 40 (5), S. 243 - 243 (2007)

Kohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Lieb, R. et al.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 40 (5), S. 212 - 212 (2007)

Liebl, C.; Schuelke, J.; Schmidt, M. V.; Truembach, D.; Rein, T.; Müller, M. B.: Analysis of gene expression and regulation of a novel, stress-inducible transcript in the mouse. Pharmacopsychiatry 40 (5), S. 245 - 245 (2007)

Ohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Fey, K. et al.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with age-at-onset of depressive disorder and attempted suicide. Pharmacopsychiatry 40 (5), S. 211 - 212 (2007)

Sievers, C.; Dimopoulou, C.; Pfister, H.; Lieb, R.; Steffin, B.; Roemmler, J.; Schopohl, J.; Mueller, M.; Schneider, H. J.; Ising, M. et al.; Wittchen, H. U.; Stalla, G. K.: A shifted psychopathological risk profile in acromegalic patients? Experimental and Clinical Endocrinology & Diabetes 115 (8), S. 553 - 553 (2007)

Thoeringer, C. K.; Sillaber, I.; Roedel, A.; Erhardt, A.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: An in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice. Psychoneuroendocrinology 32 (6), S. 746 - 757 (2007)

Schmidt, M. V.; Sterlemann, V.; Ganea, K.; Liebl, C.; Alam, S.; Harbich, D.; Greetfeld, M.; Uhr, M.; Holsboer, F.; Müller, M. B.: Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 32 (5), S. 417 - 429 (2007)

Ganea, K.; Liebl, C.; Sterlemann, V.; Müller, M. B.; Schmidt, M. V.: Pharmacological validation of a novel home cage activity counter in mice. Journal of Neuroscience Methods 162 (1-2), S. 180 - 186 (2007)

Ganea, K.; Sillaber, I.; Henniger, M. S. H.; Liebl, C.; Panhuysen, M.; Pütz, B.; Schmidt, M. V.; Sterlemann, V.; Storch, C.; Müller, M. B.: Identification and validation of new antidepressant-responsive gene candidates in mouse brain. European Neuropsychopharmacology 17 (Suppl. 1), S. S31 - S32 (2007)

Himmerich, H.; Nickel, T.; Dalal, M. A.; Müller, M. B.: Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis 34 (2), S. 93 - 94 (2007)

Thoeringer, C. K.; Binder, E. B.; Salyakina, D.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Brueckl, T. M.; Mueller, M. B. et al.; Fuchs, B.; Puetz, B.; Lieb, R.; Uhr, M.; Holsboer, F.; Mueller-Myhsok, B.; Keck, M.: Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. Journal of Psychiatric Research 41, doi:10.1016/j.jpsychires.2006.06.001, S. 579 - 584 (2007)

Welt, T.; Engelmann, M.; Renner, U.; Erhardt, A.; Müller, M. B.; Landgraf, R.; Holsboer, F.; Keck, M. E.: Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology 31 (12), S. 2573 - 2579 (2006)

Nguyen, N. K.; Keck, M. E.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J. M.; Holsboer, F.; Müller, M. B.; Singewald, N.: Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology 188 (3), S. 374 - 385 (2006)

Müller, M. B.; Holsboer, F.: Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 59 (12), S. 1104 - 1115 (2006)

Schmidt, M. V.; Deussing, J. M.; Oitzl, M. S.; Ohl, F.; Levine, S.; Wurst, W.; Holsboer, F.; Müller, M. B.; de Kloet, E. R.: Differential disinhibition of the neonatal hypothalamic-pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice. European Journal of Neuroscience 24, S. 2291 - 2298 (2006)

Schmidt, M. V.; Levine, S.; Alam, S.; Harbich, D.; Sterlemann, V.; Ganea, K.; de Kloet, E. R.; Holsboer, F.; Müller, M. B.: Metabolic signals modulate hypothalamic-pituitary-adrenal axis activation during maternal separation of the neonatal mouse. Journal of Neuroendocrinology 18, S. 865 - 874 (2006)

Müller, M. B.: Experimental validation of novel drug targets. Pharmacopsychiatry 38 (5), S. 265 - 265 (2005)

Müller, M. B.; Sterlemann, V.; Ganea, K.; Alam, S.; Holsboer, F.; Schmidt, M.: Towards a new animal model for stress related disorders. Behavioural Pharmacology 16 (Suppl. 1), S. S71 - S71 (2005)

Sterlemann, V.; Schmidt, M.; Alam, S.; Ganea, K.; Greetfeld, M.; Holsboer, F.; Müller, M. B.: A new model of chronic social stress in mice: long-term neuroendocrine and behavioural consequences. Pharmacopsychiatry 38 (5), S. 279 - 279 (2005)